Junji Uehori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Junji Uehori has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Anna-Lisa Lanz
Department of Pediatrics, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
1 shared publication - Axel Roers
Institute for Immunology, Heidelberg University Hospital, Heidelberg, Germany
1 shared publication - Burcu Sivri
Institute of Cardiovascular Immunology, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany
1 shared publication - Domnica Luca
Institute of Cardiovascular Immunology, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany
1 shared publication - Fabian Hauck
Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universitat, Munich, Germany; University Children's Hospital Heidelberg-Mannheim Ltd., Ruprecht-Karls-Universitat Heidelberg, Heidelberg, Germany
1 shared publication - Hiroki Kato
Institute of Cardiovascular Immunology, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany
1 shared publication
Latest Publications
- Open Access
- 1 March 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (9) , eadk0820
Aberrant RNA sensing in regulatory T cells causes systemic autoimmunity
Chronic and aberrant nucleic acid sensing causes type I IFN–driven autoimmune diseases, designated type I interferonopathies. We found a significant reduction of regulatory T cells (T regs ) in patients with type I interferonopathies caused by mutations in ADAR1 or IFIH1 (encoding MDA5). We analyzed the underlying mechanisms using murine models and found that T reg -specific deletion of Adar1 caused peripheral T reg loss and scurfy -like lethal autoimmune disorders. Similarly, knock-in mice with T reg -specific expression of an MDA5 gain-of-function mutant caused apoptosis of peripheral T regs and severe autoimmunity. Moreover, the impact of ADAR1 deficiency on T regs is multifaceted, involving both MDA5 and PKR sensing. Together, our results highlight the dysregulation of T reg homeostasis by intrinsic aberrant RNA sensing as a potential determinant for type I interferonopathies.
- 1 March 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (9) , eadk0820
Open AccessAberrant RNA sensing in regulatory T cells causes systemic autoimmunity
Chronic and aberrant nucleic acid sensing causes type I IFN–driven autoimmune diseases, designated type I interferonopathies. We found a significant reduction of regulatory T cells (T regs ) in patients with type I interferonopathies caused by mutations in ADAR1 or IFIH1 (encoding MDA5). We analyzed the underlying mechanisms using murine models and found that T reg -specific deletion of Adar1 caused peripheral T reg loss and scurfy -like lethal autoimmune disorders. Similarly, knock-in mice with T reg -specific expression of an MDA5 gain-of-function mutant caused apoptosis of peripheral T regs and severe autoimmunity. Moreover, the impact of ADAR1 deficiency on T regs is multifaceted, involving both MDA5 and PKR sensing. Together, our results highlight the dysregulation of T reg homeostasis by intrinsic aberrant RNA sensing as a potential determinant for type I interferonopathies.